Amplitude Surgical (AMPLI) H1 24/25 earnings summary

Executive summary

• Consolidated sales reached €51.5 million in H1 2024-25, up 6.3% at constant exchange rates compared to H1 2023-24.

• Growth driven by strong international subsidiary performance and continued momentum in France.

Financial highlights

• Sales increased 5.0% at current exchange rates and 6.3% at constant exchange rates year-over-year.

• Q2 sales totaled €29.8 million, up 5.3% at constant exchange rates from Q2 2023-24.

• Direct sales (France and international subsidiaries) represented 93% of total sales, rising 6.4% at constant exchange rates.

Segment performance

• France accounted for 71% of group sales in H1 2024-25, growing 4.6% year-over-year.

• International subsidiaries saw 12.6% sales growth at constant exchange rates, with strong results in Belgium, Australia, Brazil, and South Africa.

• Sales in Germany and Switzerland declined.

• International distributors grew 3.8% at constant exchange rates.